Changjiang Daily-Changjiang Network November 15 News On the morning of November 15, in the Mingzhi Medical Laboratory, a wholly-owned subsidiary of Wuhan Mingde Biotechnology Co., Ltd., technicians were conducting nucleic acid testing on cold chain frozen specimens collected from the East and West Lakes district. Because of the tight working hours and heavy tasks of testing, Chen Lili, chairman of Mingde Biologics, took time to the scene to supervise the battle.
Last week, the Wuhan Federation of Industry and Commerce and the Wuhan Yichang Chamber of Commerce jointly recommended Chen Lili to participate in the 2020 "Influence Wuhan" Economic Figure Selection, on the grounds that she and Mingde Biology have made outstanding contributions in helping Hubei Wuhan and even the national and global fight against the epidemic.
(Pictured is Chen Lili, chairman of Mingde Biologics.) Photo courtesy of me)
Lili Chen founded Mingde Biologics in 2008. The name "Matilda" comes from the opening chapter of one of the "Four Books", "The University", "The Way of the University, in Mingmingde". Chen Lili's original intention is to let POCT (instant diagnosis) spread throughout China, so that rapid diagnosis can benefit ordinary people. Fight for more rescue opportunities for patients.
After the outbreak of the epidemic this year, Chen Lili set up a scientific research team to develop related testing products. From supply chain resource allocation to research and development, she has been in the front line of command. Various objective conditions are limited, the initial stage of research and development work is not smooth, in order to overcome difficulties, many R & D personnel in the reagent department work more than 15 hours a day. Looking back on those days more than 9 months later, Chen Lili lamented that "Mingde people really fought for the prevention and control of the epidemic."
In March, Mingde Bio has launched two detection products, the new coronavirus (2019-nCoV) nucleic acid detection kit (multiplex fluorescence PCR method) and the new coronavirus IgM/IgG antibody detection kit (colloidal gold method), becoming the first successful R&D enterprise in the province.
Mingde Bio's reagent products have shown good performance and operation experience, and have entered nearly 1,000 medical institutions, third-party testing institutions and overseas markets. Statistics show that in the first three quarters, Mingde has released more than 10 million nucleic acid and antibody detection reagents at home and abroad. Mingde also undertook the task of ensuring the supply of reagents for a quarter of the wuhan national screening, and Mingde people entered the community for the first time in mid-May to carry out operations. Mingzhi Medical Laboratory invested more than 400 professionals to provide field collection services for enterprises, communities and schools, and the laboratory testing equipment continued to operate 24 hours a day, issued reports within 48 hours, and had a daily testing capacity of 50,000 person-times. At the same time, Mingde donated medical equipment and testing reagents to domestic and international regional and medical institutions in demand with a market value of more than 10 million yuan.
On November 13, Mingzhi Medical Laboratory received a commission from the East-West Lake District Cd-operative Center for Disease Control and Prevention to fully assist the cold chain frozen product testing work in the district. Dongxihu District has the largest cold chain warehouse of frozen products in the city. Technicians collect frozen specimens one by one at the site, seal them strictly and send them back to the laboratory for testing. "For the sake of food safety for the people in their hometown, Mingde people are waiting for it." Chen Lili said.
Last month, the planned investment of 600 million yuan in the Mingde Biological Production and Research and Development Smart Medical Base Project began construction in Optics Valley. This in vitro diagnostic product industrial park aimed at the construction of first-class standards in China carries the "14th Five-Year Plan" of Mingde Biologics. Chen Lili said: "Innovation is always the soul of enterprises and entrepreneurs. We are expanding the whole chain product line, continuing to carry out in-depth core research and development, and striving to break through the 'card neck' technology to escort people's better life." ”
(Reporter Wen Tao, Correspondent Hu Xueying, Gao Aimin, Peng Ying)
Attached: Click the link below to register for the selection
@ Wuhan entrepreneur, please pick up the hero post, "influence Wuhan" economic figure selection registration launched
【Editor: Zhu Chenying】
![Fujian opera Wudan Chen Lili appeared on CCTV on the evening of the 8th[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)